Checkpoint inhibitors can do remarkable things against advanced cancer, but only for some patients, and oncologists are still poor at saying in advance who. New work in Nature Medicine, out June 25, points to an unexpected place to look for clues: the small molecules left in a patient's blood after the body finishes its everyday chemistry. One amino acid, histidine, kept turning up as a good sign.
Reading the blood
The team was large and international, and so was the haul of data: 4,336 plasma samples from 1,714 patients, five cancer types, 16 separate study groups across Europe and North America, sampled again and again through treatment. They measured 154 metabolites in each sample, sequenced the gut microbiome alongside, then handed the lot to a machine-learning model together with plain clinical details like age and kidney function.
Histidine, of all things
The model boiled its prediction down to five metabolites plus a few clinical numbers, and used them to guess whether a patient would still be free of cancer progression a year later. It scored 0.88 on the data it trained on and 0.73 on fresh patients, and roughly held that across seven more outside groups. High histidine tracked with good outcomes. High long-chain fatty acids and succinate went the other way. Then the researchers pushed past correlation. In mice, extra histidine sharpened the immune attack on tumors. In people, histidine-rich diets lined up with longer time before progression, mostly in patients whose gut bacteria were not busy breaking the histidine down.
Before anyone raids the supplement aisle
A validation score of 0.73 is a promising signal, not a test a doctor can lean on yet, and most of the human results are associations rather than proof. The diet angle in particular is not advice. Nobody should start eating for histidine on the strength of this. What the paper delivers is a sharp, checkable idea, that a patient's metabolism and microbes help decide whether immunotherapy lands, along with a sense of which trials would settle it.
Comments